Categories: science

  • ”Svensk bioteknik på väg att förändra spelplanen” – Onkologi i Sverige

    I sitt senaste reportage i Onkologi i Sverige lyfter Ulrika Nyberg fram vårt arbete på Anocca – ett svenskt biotechbolag som nu är på väg in i klinik med nästa generations TCR-T-cellterapi. I artikeln får läsaren inblick i hur svensk teknologi, ingenjörskonst och systemtänkande kan utmana globala strukturer inom cancervård. Finns här en historia som rör mer än bara vetenskap.

  • The TCR-T cell therapies of tomorrow

    By Jim Cornall, Labiotech.eu/Beyond Biotech
    Links to the podcastBeyond Biotech: https://rb.gy/531d7aSpotify: https://rb.gy/y2e6exApple Podcast: https://rb.gy/g9obfkAmazon Music: https://rb.gy/6bf1ba

Enter your email address to follow Anocca AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Anocca AB.

Okay